Single-dose SARS-CoV-2 vaccination efficacy in the elderly

Lancet Infect Dis. 2021 Nov;21(11):1474-1475. doi: 10.1016/S1473-3099(21)00354-6. Epub 2021 Jun 23.

Authors

Maria Prendecki¹, Michelle Willicombe²

Affiliations

¹ Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK. Electronic address: m.prendecki@imperial.ac.uk.
² Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK.

No abstract available

Publication types

Comment

MeSH terms

Aged
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2*
Spike Glycoprotein, Coronavirus
Vaccination

Substances

COVID-19 Vaccines
Spike Glycoprotein, Coronavirus